Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.68+0.05 (+0.98%)
Close on Nov 17, 2026Market cap $150.87MP/E –Yield –
Inogen r&d expenses
Research and development expenses are spending on new products and technology.
Inogen's R&D Expenses for the twelve months ending Jun 30, 2026 was $21.12M, up 13.2% year over year. For fiscal 2025 it was $19.40M, down 10.2% from the year before. Over ten years it grew 16.6% a year on average. The highest annual figure on record is $21.94M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.40M | -10.2% |
| FY2024 | Dec 31, 2024 | $21.61M | +3.7% |
| FY2023 | Dec 31, 2023 | $20.84M | -5.0% |
| FY2022 | Dec 31, 2022 | $21.94M | +32.4% |
| FY2021 | Dec 31, 2021 | $16.58M | +17.7% |
| FY2020 | Dec 31, 2020 | $14.08M | +49.8% |
| FY2019 | Dec 31, 2019 | $9.40M | +33.7% |
| FY2018 | Dec 31, 2018 | $7.03M | +32.3% |
| FY2017 | Dec 31, 2017 | $5.31M | +3.9% |
| FY2016 | Dec 31, 2016 | $5.11M | +22.3% |
| FY2015 | Dec 31, 2015 | $4.18M | +40.4% |
| FY2014 | Dec 31, 2014 | $2.98M | +24.1% |
| FY2013 | Dec 31, 2013 | $2.40M | +6.0% |
| FY2012 | Dec 31, 2012 | $2.26M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.87M | +12.7% |
| Q1 FY2026 | Mar 31, 2026 | $5.10M | +26.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.32M | -9.9% |
| Q3 FY2025 | Sep 30, 2025 | $4.84M | +37.6% |
| Q2 FY2025 | Jun 30, 2025 | $5.21M | -7.2% |
| Q1 FY2025 | Mar 31, 2025 | $4.03M | -38.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.90M | -12.2% |
| Q3 FY2024 | Sep 30, 2024 | $3.52M | -21.6% |
| Q2 FY2024 | Jun 30, 2024 | $5.62M | +30.8% |
| Q1 FY2024 | Mar 31, 2024 | $6.58M | +23.1% |
| Q4 FY2023 | Dec 31, 2023 | $6.71M | +13.1% |
| Q3 FY2023 | Sep 30, 2023 | $4.49M | -2.0% |
| Q2 FY2023 | Jun 30, 2023 | $4.29M | -29.2% |
| Q1 FY2023 | Mar 31, 2023 | $5.34M | -0.4% |
| Q4 FY2022 | Dec 31, 2022 | $5.93M | +26.7% |
| Q3 FY2022 | Sep 30, 2022 | $4.58M | +22.0% |
| Q2 FY2022 | Jun 30, 2022 | $6.06M | +47.1% |
| Q1 FY2022 | Mar 31, 2022 | $5.36M | +33.6% |
| Q4 FY2021 | Dec 31, 2021 | $4.68M | +27.5% |
| Q3 FY2021 | Sep 30, 2021 | $3.75M | +6.9% |
| Q2 FY2021 | Jun 30, 2021 | $4.12M | +25.3% |
| Q1 FY2021 | Mar 31, 2021 | $4.02M | +11.4% |
| Q4 FY2020 | Dec 31, 2020 | $3.67M | +1.3% |
| Q3 FY2020 | Sep 30, 2020 | $3.51M | +33.2% |
| Q2 FY2020 | Jun 30, 2020 | $3.29M | +124.1% |
| Q1 FY2020 | Mar 31, 2020 | $3.61M | +116.0% |
| Q4 FY2019 | Dec 31, 2019 | $3.63M | +108.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.64M | +25.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.47M | -17.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.67M | +17.9% |
| Q4 FY2018 | Dec 31, 2018 | $1.74M | +27.2% |
| Q3 FY2018 | Sep 30, 2018 | $2.10M | +52.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.78M | +40.9% |
| Q1 FY2018 | Mar 31, 2018 | $1.42M | +8.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.37M | +12.6% |
| Q3 FY2017 | Sep 30, 2017 | $1.38M | +1.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.26M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.31M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.22M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.35M | – |
See a number that looks wrong?